Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

502
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
502
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

394
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
394
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

782
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
782
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

704
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
704
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.0K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of Toric Intraocular Lens Formulas in Eyes With Previous Myopic Laser Vision Correction.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2026
Same author

A case of carbapenamase production in <i>Shigella flexneri</i> isolated in Ireland, 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Steroid-Refractory Warm Autoimmune Haemolytic Anaemia Complicating Ulcerative Colitis in Pregnancy: A Case Report and Management Considerations.

Cureus·2026
Same author

Predicting the Risk of Decompensation in Patients With Cirrhosis: A Validated Machine Learning Approach.

The American journal of gastroenterology·2026
Same author

Inpatient and post-discharge thromboembolic events in inflammatory bowel disease patients: a 13 year retrospective cohort study at a tertiary Centre.

Scandinavian journal of gastroenterology·2026
Same author

Quality metrics reflecting patient experience of gastrointestinal endoscopy in inflammatory bowel disease: results of national endoscopy dataset analysis.

Journal of Crohn's & colitis·2026

Related Experiment Video

Updated: Jan 6, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K

Re-evaluating Gastric Ulcer Re-evaluation: Low Malignancy Yield and High Cost in a 19-Year Retrospective Cohort

Thomas Matthews1, Mark Vesey2,3, Aditya Billur3

  • 1Department of Gastroenterology, Mater Misericordiae University Hospital, Dublin, Ireland. thomasmatthews@mater.ie.

Journal of Gastrointestinal Cancer
|December 1, 2025
PubMed
Summary
This summary is machine-generated.

Routine re-evaluation of gastric ulcers (GUs) with benign features and adequate histology offers minimal benefit and incurs high costs. A selective approach targeting suspicious ulcers is more effective for gastric cancer detection and resource allocation.

Keywords:
BiopsyGastroscopyHealthcare costsStomach neoplasmsStomach ulcer

More Related Videos

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

4.1K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.0K

Related Experiment Videos

Last Updated: Jan 6, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K
Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

4.1K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.0K

Area of Science:

  • Gastroenterology
  • Oncology
  • Health Economics

Background:

  • Routine endoscopic re-evaluation of gastric ulcers (GUs) is standard practice to rule out malignancy.
  • The necessity and cost-effectiveness of universal GU surveillance are increasingly questioned, especially in low-to-intermediate gastric cancer prevalence areas.

Purpose of the Study:

  • To assess adherence to guidelines for repeat gastroscopy in GUs.
  • To identify predictors of malignancy in GUs.
  • To evaluate the diagnostic yield and healthcare costs associated with GU re-evaluation.

Main Methods:

  • Retrospective analysis of 2132 index GUs from 56,874 gastroscopies (May 2006 - August 2024).
  • Data collected included demographics, endoscopic, and histological findings.
  • Malignancy outcomes were tracked via histology databases; logistic regression identified malignancy predictors.

Main Results:

  • Gastric malignancies were found in 4% (86/2132) of GUs, with 96% detected at initial biopsy.
  • Macroscopic concern was the strongest malignancy predictor (OR 66.9), followed by older age, male sex, and non-antral location.
  • Routine surveillance of benign ulcers yielded no cancers; re-evaluations cost over €1 million and represented 2.5% of endoscopy workload.

Conclusions:

  • Routine re-evaluation of benign GUs with adequate histology offers minimal diagnostic value and significant cost.
  • A selective surveillance strategy focusing on ulcers with suspicious features, inadequate biopsies, or persistent symptoms is recommended.
  • This approach optimizes resource allocation and reduces unnecessary endoscopic procedures.